Purdue is dedicating a lot of energy toward addressing diabetes with 5 new technologies
More than 29 million Americans have diabetes and 86 million have prediabetes. Purdue University researchers are focusing on new innovations in treatment.
More than 29 million Americans have diabetes and 86 million have prediabetes. Purdue University researchers are focusing on new innovations in treatment.
A research team at the University of Virginia School of Medicine is looking to automate the monitoring of blood glucose levels and insulin for type 1 diabetes patients.
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
A three-month experiment in Canada with bimonthly text messages, a Web portal and home-based medical devices produced an average weight decrease of 3.5 pounds and a mean reduction in hemoglobin A1c levels from 7.41 to 6.77 percent in Type 2 diabetics.
Omada Health CEO Sean Duffy views the results as further evidence that even technology challenged seniors can successfully use digital health tools to improve their health.
The point-of-care diagnostics market is continuing to grow - blood testing and monitoring infectious diseases will be much more advanced.
So many health apps, so few users, unless they're sick. But, hey — surprise — HealthMine has the perfect wellness program for those who do use apps.
Glooko, a digital health buiness, has added a series of devices to a recently launched platform designed to aggregate not only data from blood-gluose meters and insulin pumps.
Joslin Diabetes Center has named a replacement one week after John Brooks III said he was forced to resign as CEO after five years in the role, according to media reports.
Philips Healthcare has unveiled an app for people with Type 1 diabetes, the first of a series of apps for people with chronic conditions.
More big news for Dexcom. Its G5 continuous glucose monitor will soon be available for use in several European countries.
We will highlight Build My Health's revenue practice management tools, which could help physician practices add up to $250,000 to their practices.
GlaxoSmithKline's new COPD drug unfortunately failed to extend life in those involved with a major clinical trial, and 50 percent of Americans have diabetes or pre-diabetes, putting them at risk for developing the chronic condition.
No diabetes yet. Instead, presbyopia.
In healthcare, we have our own Pareto principle: 80% of healthcare costs are attributed to 20% of the populace: the chronically ill.
Novo Nordisk has acquired Indiana-based Calibrium LLC and MB2 LLC, which are developing drugs for diabetes and metabolic diseases, some health insurers are dramatically increasing rates.
Rhode Island biopharma company VeroScience aims to understand Circadian rhythms, harnessing the biological clock to treat diseases like type 2 diabetes and cancer.